- Report
- February 2024
- 250 Pages
Global
From €4797EUR$5,000USD£4,148GBP
- Report
- May 2020
- 117 Pages
Global
From €3982EUR$4,150USD£3,443GBP
- Report
- April 2021
- 50 Pages
China
From €2495EUR$2,600USD£2,157GBP
- Report
- September 2022
- 145 Pages
Global
From €4078EUR$4,250USD£3,526GBP
Plaquenil is a brand name for the generic drug hydroxychloroquine, an immune disorder drug used to treat and prevent malaria. It is also used to treat rheumatoid arthritis, lupus, and porphyria cutanea tarda. Plaquenil works by reducing inflammation and suppressing the immune system. It is usually taken orally, but can also be administered intravenously. Common side effects include nausea, vomiting, and headache.
Plaquenil is a widely used drug in the treatment of immune disorders. It is often prescribed as a first-line treatment for rheumatoid arthritis and lupus, and is also used to treat other autoimmune diseases. It is generally well-tolerated and has few serious side effects.
The Plaquenil market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more